IWS
REGN icon

Insight Wealth Strategies’s Regeneron Pharmaceuticals REGN Stock Holding History

Insight Wealth Strategies’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.53M Sell
8,617
-117
-1% -$88.4K 0.65% 50
2026
Q2 		$5.46M Buy
8,734
+1,850
+27% +$1.26M 0.53% 65
2026
Q1 		$5.32M Sell
6,884
-612
-8% -$469K 0.59% 57
2025
Q4 		$5.79M Buy
7,496
+218
+3% +$148K 0.66% 40
2025
Q3 		$4.09M Buy
+7,278
New +$4.12M 0.48% 69
2021
Q2 		– Sell
-429
Closed -$203K – 226
2021
Q1 		$203K Sell
429
-6
-1% -$2.92K 0.03% 214
2020
Q4 		$210K Buy
435
+77
+22% +$41.6K 0.04% 215
2020
Q3 		$200K Buy
358
+34
+10% +$20.6K 0.04% 196
2020
Q2 		$202K Buy
+324
New +$184K 0.05% 165

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
CBT
Central Bank & Trust Lexington, Kentucky $701M AUM 26.18% 1-Year Est. Return

Insight Wealth Strategies's REGN Position: Q3 2026 in Review

Insight Wealth Strategies reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q3 2026, selling an estimated $88.4K and leaving 8,617 shares worth $6.53M. The position accounts for 0.65% of the portfolio, ranked #50.

Insight Wealth Strategies first reported a position in REGN in Q2 2020 and has held it in 9 quarters since. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Insight Wealth Strategies held 8,617 shares of Regeneron Pharmaceuticals worth $6.53M as of Q3 2026.
  • Insight Wealth Strategies sold 117 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $88.4K.
  • Regeneron Pharmaceuticals made up 0.65% of Insight Wealth Strategies's portfolio in Q3 2026, its #50 holding.
  • Insight Wealth Strategies first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Insight Wealth Strategies's 13F filing for Q3 2026, filed 9 Oct 2026.